Trials / Completed
CompletedNCT06574750
Effect of a New HA Filler in Correcting Nasolabial Fold
New HA Filler Versus Juvederm for Nasolabial Fold Correction
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The investigators aimed to evaluate the efficacy and safety of new HA filler for nasolabial fold correction
Detailed description
A 24-week prospective, single-center, assessor-blinded, randomized, split-face study was conducted to compare the clinical efficacy and safety of new HA filler versus Juvederm for nasolabial fold correction
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CUREAⓇ (ARIBIO, Ltd., Seoul, Republic of Korea) | Hyaluronic acid filler injection were administered into the mid-dermis of the nasolabial fold. |
| DRUG | JuvedermⓇ (Q-Med AB, Uppsala, Sweden) | Hyaluronic acid filler injection were administered into the mid-dermis of the nasolabial fold. |
Timeline
- Start date
- 2021-10-16
- Primary completion
- 2023-05-08
- Completion
- 2023-05-08
- First posted
- 2024-08-28
- Last updated
- 2024-08-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06574750. Inclusion in this directory is not an endorsement.